187 related articles for article (PubMed ID: 34725942)
1. The association between vincristine-induced peripheral neuropathy and health-related quality of life in children with cancer.
van de Velde ME; van den Berg MH; Kaspers GJL; Abbink FCH; Twisk JWR; van der Sluis IM; van den Bos C; van den Heuvel-Eibrink MM; Segers H; Chantrain C; van der Werff Ten Bosch J; Willems L; van Litsenburg RRL
Cancer Med; 2021 Nov; 10(22):8172-8181. PubMed ID: 34725942
[TBL] [Abstract][Full Text] [Related]
2. Measuring vincristine-induced peripheral neuropathy in children with cancer: validation of the Dutch pediatric-modified Total Neuropathy Score.
Schouten SM; van de Velde ME; Kaspers GJL; Mokkink LB; van der Sluis IM; van den Bos C; Hartman A; Abbink FCH; van den Berg MH
Support Care Cancer; 2020 Jun; 28(6):2867-2873. PubMed ID: 31732853
[TBL] [Abstract][Full Text] [Related]
3. Vincristine-induced peripheral neuropathy in children with cancer: A systematic review.
van de Velde ME; Kaspers GL; Abbink FCH; Wilhelm AJ; Ket JCF; van den Berg MH
Crit Rev Oncol Hematol; 2017 Jun; 114():114-130. PubMed ID: 28477739
[TBL] [Abstract][Full Text] [Related]
4. Vincristine-Induced Peripheral Neuropathy in Pediatric Oncology: A Randomized Controlled Trial Comparing Push Injections with One-Hour Infusions (The VINCA Trial).
van de Velde ME; Kaspers GJL; Abbink FCH; Twisk JWR; van der Sluis IM; van den Bos C; van den Heuvel-Eibrink MM; Segers H; Chantrain C; van der Werff Ten Bosch J; Willems L; van den Berg MH
Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33322788
[TBL] [Abstract][Full Text] [Related]
5. Patterns and severity of vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia.
Lavoie Smith EM; Li L; Chiang C; Thomas K; Hutchinson RJ; Wells EM; Ho RH; Skiles J; Chakraborty A; Bridges CM; Renbarger J
J Peripher Nerv Syst; 2015 Mar; 20(1):37-46. PubMed ID: 25977177
[TBL] [Abstract][Full Text] [Related]
6. CYP3A5 genotype and its impact on vincristine pharmacokinetics and development of neuropathy in Kenyan children with cancer.
Skiles JL; Chiang C; Li CH; Martin S; Smith EL; Olbara G; Jones DR; Vik TA; Mostert S; Abbink F; Kaspers GJ; Li L; Njuguna F; Sajdyk TJ; Renbarger JL
Pediatr Blood Cancer; 2018 Mar; 65(3):. PubMed ID: 29115708
[TBL] [Abstract][Full Text] [Related]
7. Randomized controlled trial on the effect of 1-hour infusion of vincristine versus push injection on neuropathy in children with cancer (final analysis).
Uittenboogaard A; van den Berg MH; Abbink FCH; Twisk JWR; van der Sluis IM; van den Bos C; van den Heuvel-Eibrink MM; Segers H; Chantrain C; van der Werff Ten Bosch J; Willems L; Kaspers GJL; van de Velde ME
Cancer Med; 2023 Oct; 12(19):19480-19490. PubMed ID: 37732486
[TBL] [Abstract][Full Text] [Related]
8. Vincristine-induced peripheral neuropathy in survivors of childhood acute lymphoblastic leukaemia.
Tay CG; Lee VWM; Ong LC; Goh KJ; Ariffin H; Fong CY
Pediatr Blood Cancer; 2017 Aug; 64(8):. PubMed ID: 28139029
[TBL] [Abstract][Full Text] [Related]
9. Population Pharmacokinetics of Vincristine Related to Infusion Duration and Peripheral Neuropathy in Pediatric Oncology Patients.
van de Velde ME; Panetta JC; Wilhelm AJ; van den Berg MH; van der Sluis IM; van den Bos C; Abbink FCH; van den Heuvel-Eibrink MM; Segers H; Chantrain C; van der Werff Ten Bosch J; Willems L; Evans WE; Kaspers GL
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32635465
[TBL] [Abstract][Full Text] [Related]
10. Model-Informed Precision Dosing to Reduce Vincristine-Induced Peripheral Neuropathy in Pediatric Patients: A Pharmacokinetic and Pharmacodynamic Modeling and Simulation Analysis.
Centanni M; van de Velde ME; Uittenboogaard A; Kaspers GJL; Karlsson MO; Friberg LE
Clin Pharmacokinet; 2024 Feb; 63(2):197-209. PubMed ID: 38141094
[TBL] [Abstract][Full Text] [Related]
11. Prospective assessment of vincristine-induced peripheral neuropathy in paediatric acute lymphoblastic leukemia.
Li T; Kandula T; Cohn RJ; Kiernan MC; Park SB; Farrar MA
Clin Neurophysiol; 2023 Oct; 154():157-168. PubMed ID: 37633123
[TBL] [Abstract][Full Text] [Related]
12. Glutamine for the treatment of vincristine-induced neuropathy in children and adolescents with cancer.
Sands S; Ladas EJ; Kelly KM; Weiner M; Lin M; Ndao DH; Dave A; Vahdat LT; Bender JG
Support Care Cancer; 2017 Mar; 25(3):701-708. PubMed ID: 27830395
[TBL] [Abstract][Full Text] [Related]
13. Genetic Polymorphisms Associated with Vincristine Pharmacokinetics and Vincristine-Induced Peripheral Neuropathy in Pediatric Oncology Patients.
van de Velde ME; Uittenboogaard A; Yang W; Bonten E; Cheng C; Pei D; van den Berg MH; van der Sluis IM; van den Bos C; Abbink FCH; van den Heuvel-Eibrink MM; Segers H; Chantrain C; van der Werff Ten Bosch J; Willems L; Evans WE; Kaspers GJL
Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884569
[TBL] [Abstract][Full Text] [Related]
14. Vincristine-induced peripheral neuropathy: A mini-review.
Li GZ; Hu YH; Li DY; Zhang Y; Guo HL; Li YM; Chen F; Xu J
Neurotoxicology; 2020 Dec; 81():161-171. PubMed ID: 33053366
[TBL] [Abstract][Full Text] [Related]
15. [A cohort study of vincristine-induced peripheral neuropathy in children].
Li C; Jin J; Huang J; Yang XY; Li Y; Yan YY; Yang C
Zhongguo Dang Dai Er Ke Za Zhi; 2023 May; 25(5):470-475. PubMed ID: 37272172
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenomics of Vincristine-Induced Peripheral Neuropathy in Children with Cancer: A Systematic Review and Meta-Analysis.
Uittenboogaard A; Neutel CLG; Ket JCF; Njuguna F; Huitema ADR; Kaspers GJL; van de Velde ME
Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158880
[TBL] [Abstract][Full Text] [Related]
17. Vincristine-induced peripheral neuropathy in pediatric cancer patients.
Mora E; Smith EM; Donohoe C; Hertz DL
Am J Cancer Res; 2016; 6(11):2416-2430. PubMed ID: 27904761
[TBL] [Abstract][Full Text] [Related]
18. Vincristine-Induced Peripheral Neuropathy (VIPN) in Pediatric Tumors: Mechanisms, Risk Factors, Strategies of Prevention and Treatment.
Triarico S; Romano A; Attinà G; Capozza MA; Maurizi P; Mastrangelo S; Ruggiero A
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33923421
[TBL] [Abstract][Full Text] [Related]
19. Obesity as a Potential Risk Factor for Vincristine-induced Peripheral Neuropathy.
Sajdyk TJ; Boyle FA; Foran KS; Tong Y; Pandya P; Smith EML; Ho RH; Wells E; Renbarger JL
J Pediatr Hematol Oncol; 2020 Oct; 42(7):e637-e640. PubMed ID: 31634238
[TBL] [Abstract][Full Text] [Related]
20. Effect of pyridoxine plus pyridostigmine treatment on vincristine-induced peripheral neuropathy in pediatric patients with acute lymphoblastic leukemia: a single-center experience.
Aydin Köker S; Gözmen S; Demirağ B; Ünalp A; Karapinar TH; Oymak Y; Gürbüz G; Öner Eİ; Vergin RC
Neurol Sci; 2021 Sep; 42(9):3681-3686. PubMed ID: 33439396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
